Skip to main content
. 2022 Mar 16;8:119. doi: 10.1038/s41420-022-00927-4

Table 3.

So far, studies of Btk inhibitors related to cardiovascular disease.

Btk inhibitors Disease References
Acalabrutinib Atherosclerosis [53,55]
ONO/GS-4059 Atherosclerosis [53,55]
Ibrutinib Atherosclerosis [53,55]
BGB-3111 Atherosclerosis [55]
Evobrutinib Atherosclerosis [55]